News For Gilead Sciences


What Analysts Suggest About Gilead Sciences Inc (NASDAQ:GILD) and Zosano Pharma Cmn (NASDAQ:ZSAN)?Apps for PC Daily - AppsforPCdaily

What Analysts Suggest About Gilead Sciences Inc (NASDAQ:GILD) and Zosano Pharma Cmn (NASDAQ:ZSAN)?Apps for PC Daily  AppsforPCdaily

Gilead Sciences Inc (NASDAQ:GILD) shares traded up 1.3% during most recent session. Wall Street analysts covering the stock are projecting that the stock will.

Google 3/18/2019 5:14:00 PM

YETI, Gilead, Dick's, FedEx and Amazon highlighted as Zacks Bull and Bear of the Day - Nasdaq

YETI, Gilead, Dick's, FedEx and Amazon highlighted as Zacks Bull and Bear of the Day  Nasdaq

For Immediate ReleaseChicago, IL - March 18, 2019 - Zacks Equity Research YETI Holdings YETI as the Bull of the Day, Gilead Sciences GILD as the Bear.

Google 3/18/2019 3:45:00 PM

Gilead Sciences (GILD) expected to achieve -45.60% earnings growth for this year - Wallstreet Investorplace

Gilead Sciences (GILD) expected to achieve -45.60% earnings growth for this year  Wallstreet Investorplace

To gauge your chances of picking a winning stock, take a close look at its fundamentals, especially its earnings-per-share growth. Earnings per share are ...

Google 3/18/2019 3:29:14 PM


Gilead Sciences, Inc. (GILD) Quant Signals Under Scrutiny as EV Hits 71576479.97 - Augusta Review

Gilead Sciences, Inc. (GILD) Quant Signals Under Scrutiny as EV Hits 71576479.97  Augusta Review

Gilead Sciences, Inc. (GILD) presently has an EV or Enterprise Value of 71576479.97. The EV helps show how the market assigns value to a company as a ...

Google 3/18/2019 3:01:30 PM

The Ghost In The Stock Market Machine: Gilead Sciences, Inc. (GILD), Senior Housing Properties Trust (SNH) - GV Times

The Ghost In The Stock Market Machine: Gilead Sciences, Inc. (GILD), Senior Housing Properties Trust (SNH)  GV Times

The first technical resistance point for Gilead Sciences, Inc. (NASDAQ:GILD) will likely come at $66.04, marking a 0.62% premium to the current level.

Google 3/18/2019 2:30:00 PM

Myelofibrosis Treatment Market Scenario 2018-2026: – North America, Europe, Asia-Pacific, South America, Middle East and Africa - Business Herald

Myelofibrosis Treatment Market Scenario 2018-2026: – North America, Europe, Asia-Pacific, South America, Middle East and Africa  Business Herald

Increase in FDA approval of pipeline drugs is expected to drive the market. Growing prevalence of myelofibrosis in developing economies drives the demand for ...

Google 3/18/2019 12:54:00 PM

Gilead Sciences (GILD) Now Covered by BMO Capital Markets - XNewsPress

Gilead Sciences (GILD) Now Covered by BMO Capital Markets  XNewsPress

BMO Capital Markets assumed coverage on shares of Gilead Sciences (NASDAQ:GILD) in a research note released on Thursday, Marketbeat.com reports.

Google 3/18/2019 12:17:22 PM

 1 2 3 4 5  ...